Literature DB >> 2292158

Radioimmunoscintigraphy of orbital metastases from ovarian carcinoma.

J Bomanji1, J Glaholm, J L Hungerford, S J Mather, M Granowska, K E Britton, R Whitelocke.   

Abstract

Radioimmunoscintigraphy with I-123 labeled monoclonal antibody HMFG1 has been used for imaging primary and metastatic ovarian neoplasms. Uptake of I-123 labeled HMFG1 is reported in a patient with an orbital metastasis from a primary ovarian adenocarcinoma. Radioimmunoscintigraphy may have a role to play in imaging metastatic orbital neoplasms.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2292158     DOI: 10.1097/00003072-199011000-00014

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  1 in total

Review 1.  The present and future of radiolabelled antibodies in oncology.

Authors:  K E Britton; M Granowska
Journal:  Ann Nucl Med       Date:  1993-08       Impact factor: 2.668

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.